Navigation Links
Westaim to deregister its common stock in the United States
Date:10/20/2008

CALGARY, Oct. 20 /PRNewswire-FirstCall/ - The Westaim Corporation announced today its intention to deregister and terminate its reporting obligations associated with its previous Nasdaq listing under Sections 12(g) and 15(d) of the U.S. Securities and Exchange Act of 1934, as amended.

The deregistration and termination in the United States will have no effect over the Company's common stock or over its shareholders. Westaim's shares will continue to trade on the TSX under the symbol WED. Additionally, the Company does not foresee any material financial effect over its assets, liabilities and results.

During 2007, the bid price of Westaim's common shares listed on Nasdaq was below US$1.00 for longer than 180 days in contravention of Nasdaq Marketplace Rule 4450(a)(5) and as a result the Company's shares were delisted from the Nasdaq and suspended from trading on October 18, 2007.

In connection with the deregistration and termination in the United States, Westaim will immediately file a Form 15F with the SEC. Upon the filing of Form 15F, the Company's reporting obligations under the Exchange Act will be suspended immediately. These reporting obligations will be finally terminated after a 90-day waiting period, provided that the SEC does not raise objections.

The Westaim Corporation's common shares are listed on The Toronto Stock Exchange under the trading symbol WED.

This news release contains forward-looking statements. These statements are based on current expectations that are subject to risks and uncertainties, and Westaim can give no assurance that these expectations are correct. Various factors could cause actual results to differ materially from those projected in such statements, including but not limited to statements regarding the Company's intention to deregister and terminate its reporting obligations associated with its previous Nasdaq listing, the anticipated filing of a Form 15F with the SEC, the date of any filing, the impact of any filing on the Company's reporting obligations, the effect of a filing upon the Company's common stock or its shareholders, continued trading of the Company's stock on the TSX, or the effect of any termination of reporting obligations on the Company's assets, liabilities and results. Westaim disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise. Accordingly, readers are advised not to place undue reliance on forward-looking statements, and should not rely on this information at any date other than the date of this news release. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.


'/>"/>
SOURCE Westaim Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Westaim announces sale of iFire Technology Ltd. assets
2. Westaim announces 2008 second quarter results
3. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Second Quarter Results
4. Westaim announces 2008 first quarter results
5. Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
6. Westaim announces 2007 year-end results
7. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
8. Westaim reduces ABCP exposure
9. Westaim announces 2007 third quarter results
10. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results
11. The Westaim Corporation update on status of short-term investments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
Breaking Medicine Technology: